ANI Pharmaceuticals, Inc. (NASDAQ:ANIP) Expected to Post Qua

Equities research analysts expect that ANI Pharmaceuticals, Inc. (NASDAQ:ANIP – Get Rating) will report $70.20 million in sales for the current fiscal quarter, according to Zacks Investment Research. Two analysts have issued estimates for ANI Pharmaceuticals’ earnings, with the highest sales estimate coming in at $71.30 million and the lowest estimate coming in at $69.10 […]

Related Keywords

Tennessee , United States , Canada , America , Nikhil Lalwani , Raymond James , Patrickd Walsh , Life Insurance Co , Zacks Investment Research , Nasdaq , Pharmaceuticals Company Profile Get Rating , Mutual Of America Capital Management , Financial Services Group Inc , Cantor Fitzgerald , Tennessee Treasury Department , Pharmaceuticals Inc , Get Rating , Zacks Investment , Investment Research , Director Patrick , America Capital Management , Services Group , Company Profile , Ani Pharmaceuticals , Nasdaq Anip , Manip , Medical , Ratings , Consensus ,